Arbutus Biopharma Corporation (ABUS) Covered Calls

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.

You can sell covered calls on Arbutus Biopharma Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ABUS (prices last updated Fri 4:16 PM ET):

Arbutus Biopharma Corporation (ABUS) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
3.64	+0.01	3.60	3.77	1.8M	-	0.7

Covered Calls For Arbutus Biopharma Corporation (ABUS)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	3.5	0.25	3.52	-0.6%	-6.1%
Jan 17	3.5	0.00	3.77	-7.2%	-41.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Arbutus Biopharma Corp. is a biopharmaceutical company, which focuses on on discovering, developing and commercializing a cure for patients suffering from chronic HBV infection, a disease of the liver caused by the hepatitis B virus. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	RKLB covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	LUNR covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	NMRA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CRVS covered calls

Want more examples? ABT Covered Calls | ACA Covered Calls